CoChat
Sign Up
Cited by 46Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline

Richardson, J. S., Keegan, D. L., Bowen, R. C., Blackshaw, S. L., Cebrian-Perez, S., Dayal, N., Saleh, S., Shrikhande, S.·1994·International Clinical Psychopharmacology
DOI 10.1097/00004850-199400910-00006
Open this paper in CoChat — free account

Abstract

After 1 week of a single-blind placebo period, and prior to being randomly assigned to receive treatment with either fluoxetine or amitriptyline, patients meeting strict criteria for a diagnosis of major depressive disorder were given an auditory verbal learning test of working memory, and a blood sample was drawn. After 3 weeks of drug treatment with either amitriptyline or fluoxetine, the patients' symptoms were evaluated, the verbal learning test was repeated, and a second blood sample was taken. The clinical evaluation, the verbal learning test and the blood drawing were repeated a third time 3 weeks after the second assessment. The amount of anticholinergic activity in the blood samples was measured by a competitive radioligand binding assay and expressed in atropine equivalents. Analyses of variance indicated that there were no significant differences at the predrug Assessment 1 between patients subsequently assigned to the fluoxetine group compared with those assigned to the amitriptyline group. At Assessments 2 and 3, the fluoxetine and the amitriptyline groups showed equal clinical improvement but patients receiving amitriptyline did not perform as well on the verbal learning task. Serum anticholinergic activity at Assessments 2 and 3 was considerably higher in the amitriptyline group. This supports the hypothesis that blockade of muscarinic receptors impairs working memory formation. Equally effective antidepressant drugs with little or no anticholinergic action, such as fluoxetine, may be preferable in patients with pre-existing mild cognitive impairment or in patients where a slight reduction in cognitive performance is not acceptable.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004850-199400910-00006

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Metadata

Authors
Richardson, J. S., Keegan, D. L., Bowen, R. C., Blackshaw, S. L., Cebrian-Perez, S., Dayal, N., Saleh, S., & Shrikhande, S.
Affiliations
  • University of Saskatchewan (CA)
  • Saskatchewan Health (CA)
Venue
International Clinical Psychopharmacology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1994
Volume
9
Issue
1
Pages
35-40
ISSN
0268-1315 (ISSN-L)
DOI
10.1097/00004850-199400910-00006
OpenAlex
W2034336048
Cited by
45
References
1
Citations by year
2024: 2 · 2021: 2 · 2019: 2 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
major depressive disorder, fluoxetine, amitriptyline, verbal learning, working memory, anticholinergic activity, muscarinic receptor blockade, antidepressant side effects, cognitive impairment, tricyclic antidepressants, selective serotonin reuptake inhibitors
MeSH terms
Adolescent, Adult, Aged, Amitriptyline, Animals, Brain, Depressive Disorder, Female, Fluoxetine, Humans, Male, Memory, Short-Term, Middle Aged, Quinuclidinyl Benzilate, Mental Recall, Receptors, Muscarinic, Verbal Learning, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review